Sort
46,585 grants matching “heart failure”
Longtitudinal Studies of HIV-Associated Bacterial Pneumonia
$797,912William N Rom · New York University School Of Medicine · R01 · FY2010 · HL
Catheter for Complex Percutaneous Coronary Intervention
$797,759Tim Alexander Fischell · Crossliner Inc · R44 · FY2021 · HL
Novel Anti-HCMV Strategies
$797,740Gary Ching Tao Chan · Upstate Medical University · R01 · FY2018 · HL
Multiscale mechanobiology of right ventricular failure
$797,719Naomi C Chesler · University Of California-Irvine · R01 · FY2024 · HL
Diet and Exercise in Type 2 Diabetes
$797,675Kerry J. Stewart · Johns Hopkins University · R01 · FY2010 · HL
Neighborhood Greenness and Cardiometabolic Health among Hispanics in the HCHS/SOL Study
$797,565Scott Charles Brown · University Of Miami School Of Medicine · R01 · FY2020 · HL
Desmosomes in cardiomyocyte homeostasis and disease
$797,564William T Pu · Boston Children'S Hospital · R01 · FY2025 · HL
A FUNCTIONAL GENOMICS HEART &LUNG DEVELOP. PROGRAM
$797,461Children'S Research Institute · U01 · FY2003 · HL
Development of a Pediatric Total Artificial Heart
$797,367William J Weiss · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2016 · HL
Role of RhoA in the Molecular Pathogenesis of Heart Disease.
$797,343Maria Irene Kontaridis · Masonic Medical Research Laboratory, Inc · R01 · FY2020 · HL
Targeted inhibition of fibrosis for the prevention of heart failure
$797,333Jason R. McCarthy · Masonic Medical Research Laboratory, Inc · R01 · FY2018 · HL
CORAL: Data Coordinating Center
$797,275Donald Cutlip · Beth Israel Deaconess Medical Center · U01 · FY2013 · HL
High Deductible Health Plans and Receipt of Recommended Medical Care
$797,257Risha Gidwani Marszowski · Rand Corporation · R01 · FY2022 · AG
Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery
$797,215Amanda A Fox · Ut Southwestern Medical Center · R01 · FY2020 · HL
Circulating Proteomics to Phenotype the Development and Reversal of Myocardial Remodeling in Aortic Stenosis
$797,168Brian Richard Lindman · Vanderbilt University Medical Center · R01 · FY2023 · HL
Case-Management & Environmental Support to Sustain Weight Loss & Reduce CHD Risk
$797,117Randall Scott Stafford · Stanford University · R01 · FY2008 · HL
Targeted inhibition of fibrosis for the prevention of heart failure
$797,039Jason R. McCarthy · Masonic Medical Research Laboratory, Inc · R01 · FY2019 · HL
Genetic Engineering of Vein Bypass Grafts in Vascular and Cardiovascular Surgery
$796,784Frank W Logerfo · Beth Israel Deaconess Medical Center · R01 · FY2022 · HL
NAD+ precursor supplementation with exercise training to improve aerobic capacity in Friedreich's Ataxia
$796,719Shana Erin McCormack · Children'S Hosp Of Philadelphia · R01 · FY2024 · HL
Precision Phenomics to Personalize Drug Therapy (P3DT)
$796,664Joshua C. Denny · Vanderbilt University · P50 · FY2015 · GM
Cardiac delivery of RNA to treat contractile disorder
$796,655Kenneth Ber Margulies · University Of Pennsylvania · R01 · FY2025 · HL
Cardiopulmonary structure and function in Multi-Ethnic Study of Atherosclerosis
$796,624R Graham Barr · Columbia University Health Sciences · R01 · FY2012 · HL
1/2 Self-directed mobile adaptive coping skills intervention to improve psychological distress symptoms among cardiorespiratory failure survivors: the Blueprint RCT
$796,582Christopher Ethan Cox · Duke University · UH3 · FY2025 · HL
Predicting response to non-PAP therapies in OSA using PSG-derived endotypes
$796,458David A Wellman · Brigham And Women'S Hospital · R01 · FY2025 · HL
Predicting response to non-PAP therapies in OSA using PSG-derived endotypes
$796,458David A Wellman · Brigham And Women'S Hospital · R01 · FY2023 · HL